A Review of in vitro Platforms for Understanding Cardiomyocyte Mechanobiology

Frontiers in Bioengineering and Biotechnology

Yu Suk Choi¹  Ian L. Chin¹  Livia Hool² 

[1] School of Human Sciences, The University of Western Australia, Perth, WA, Australia;Victor Chang Cardiac Research Institute, Sydney, NSW, Australia;

关键词: heart disease;    biomaterials;    hydrogels;    cardiovascular disease;    mechanosensation;    elasticity;   

DOI  :  10.3389/fbioe.2019.00133

来源: DOAJ

【 摘 要 】

Mechanobiology—a cell's interaction with its physical environment—can influence a myriad of cellular processes including how cells migrate, differentiate and proliferate. In many diseases, remodeling of the extracellular matrix (ECM) is observed such as tissue stiffening in rigid scar formation after myocardial infarct. Utilizing knowledge of cell mechanobiology in relation to ECM remodeling during pathogenesis, elucidating the role of the ECM in the progression—and perhaps regression—of disease is a primary focus of the field. Although the importance of mechanical signaling in the cardiac cell is well-appreciated, our understanding of how these signals are sensed and transduced by cardiomyocytes is limited. To overcome this limitation, recently developed tools and resources have provided exciting opportunities to further our understandings by better recapitulating pathological spatiotemporal ECM stiffness changes in an in vitro setting. In this review, we provide an overview of a conventional model of mechanotransduction and present understandings of cardiomyocyte mechanobiology, followed by a review of emerging tools and resources that can be used to expand our knowledge of cardiomyocyte mechanobiology toward more clinically relevant applications.

【 授权许可】

Unknown